Document is current
Any future updates will be listed below
-
Authors
Huynh, Duc
Winter, Pia
Märkl, Florian
Endres, Stefan
Kobold, Sebastian https://orcid.org/0000-0002-5612-4673
-
Funding
Funding for this research was provided by:
European Research Council (756017)
Universitätsklinik München
- License Information
-
More Information
Article History
Received: 29 July 2022
Accepted: 5 September 2022
First Online: 27 September 2022
Declarations
:
: S.K. has received honoraria from TCR2 Inc., Novartis, BMS, and GSK. S.K. and S.E. are inventors of several patents in the field of immuno-oncology. S.K. and S.E. received license fees from TCR2 Inc. and Carina Biotech. S.K. and S.E. received research support from TCR2 Inc., Arcus Bioscience, and Tabby Therapeutics for work unrelated to the manuscript. All remaining authors have no conflicts of interest to declare.
